CY1113544T1 - Φαρμακευτικη συνθεση που περιλαμβανει ενα συνδυασμο που σχηματιζεται απο τον αντιμικροβιακο παραγοντα σιπροφλοξασινη και τον αντιοξειδωτικο παραγοντα ασκορβικο οξυ για τη θεραπεια λοιμωξεων του ουροποιητικου συστηματος - Google Patents
Φαρμακευτικη συνθεση που περιλαμβανει ενα συνδυασμο που σχηματιζεται απο τον αντιμικροβιακο παραγοντα σιπροφλοξασινη και τον αντιοξειδωτικο παραγοντα ασκορβικο οξυ για τη θεραπεια λοιμωξεων του ουροποιητικου συστηματοςInfo
- Publication number
- CY1113544T1 CY1113544T1 CY20131100025T CY131100025T CY1113544T1 CY 1113544 T1 CY1113544 T1 CY 1113544T1 CY 20131100025 T CY20131100025 T CY 20131100025T CY 131100025 T CY131100025 T CY 131100025T CY 1113544 T1 CY1113544 T1 CY 1113544T1
- Authority
- CY
- Cyprus
- Prior art keywords
- ascorbic acid
- ciprofloxacin
- infections
- treatment
- pharmaceutical compositions
- Prior art date
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title abstract 6
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 title abstract 4
- 239000004599 antimicrobial Substances 0.000 title abstract 2
- 239000003963 antioxidant agent Substances 0.000 title abstract 2
- 235000010323 ascorbic acid Nutrition 0.000 title abstract 2
- 239000011668 ascorbic acid Substances 0.000 title abstract 2
- 229960005070 ascorbic acid Drugs 0.000 title abstract 2
- 229960003405 ciprofloxacin Drugs 0.000 title abstract 2
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000002485 urinary effect Effects 0.000 title 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
- 229930003268 Vitamin C Natural products 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 235000006708 antioxidants Nutrition 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000011885 synergistic combination Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 208000019206 urinary tract infection Diseases 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Η παρούσα εφεύρεση αφορά μία φαρμακευτική σύνθεση που σχηματίζεται από τον συνεργικό συνδυασμό ενός αντι-μικροβιακού παράγοντα, γνωστού ως σιπροφλοξασίνη και ενός αντιοξειδωτικού παράγοντα, τέτοιου όπως το ασκορβικό οξύ (Βιταμίνη Γ), καθώς επίσης και φαρμακευτικά αποδεκτά έκδοχα που τυποποιούνται όλα σε μια ενιαία μονάδα, με μία δόση που πρόκειται να χορηγείται δια του στόματος , που χρησιμοποιείται για τη θεραπεία ουρολοιμώξεων, ο οποίος παρέχει μεγαλύτερο θεραπευτικό αποτέλεσμα, αύξηση στην τήρηση της θεραπείας και μείωση της λοίμωξης σε λιγότερο χρόνο.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2007006334A MX2007006334A (es) | 2007-05-28 | 2007-05-28 | Composicion farmaceutica que comprende la combinacion de un agente antimicrobiano y un agente antioxidante para el tratamiento de infecciones urinarias. |
EP08766681A EP2149374B1 (en) | 2007-05-28 | 2008-05-28 | Pharmaceutical composition comprising the combinaton of the anti-microbial agent ciprofloxacin and the antioxidant agent ascorbic acid for the treatment of urinary infections |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1113544T1 true CY1113544T1 (el) | 2016-06-22 |
Family
ID=40075300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20131100025T CY1113544T1 (el) | 2007-05-28 | 2013-01-10 | Φαρμακευτικη συνθεση που περιλαμβανει ενα συνδυασμο που σχηματιζεται απο τον αντιμικροβιακο παραγοντα σιπροφλοξασινη και τον αντιοξειδωτικο παραγοντα ασκορβικο οξυ για τη θεραπεια λοιμωξεων του ουροποιητικου συστηματος |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP2149374B1 (el) |
AR (1) | AR067320A1 (el) |
BR (1) | BRPI0811627A2 (el) |
CL (1) | CL2008001536A1 (el) |
CO (1) | CO6241114A2 (el) |
CY (1) | CY1113544T1 (el) |
EC (1) | ECSP099733A (el) |
ES (1) | ES2394736T3 (el) |
GT (1) | GT200900295A (el) |
MX (1) | MX2007006334A (el) |
PE (1) | PE20090316A1 (el) |
PL (1) | PL2149374T3 (el) |
WO (1) | WO2008147167A1 (el) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180360855A1 (en) * | 2015-12-25 | 2018-12-20 | Yusuf Toktamis ÖGÜN | The formulation comprising phosphomycine and ascorbic acid for the treatment of bacterial urinary system infections |
RU2637650C2 (ru) * | 2016-03-29 | 2017-12-05 | Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ" | Композиция для профилактики заболеваний мочевыводящих путей |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020169112A1 (en) * | 2001-05-08 | 2002-11-14 | Luc Montagnier | Combined treatments and methods for treatment of mycoplasma and mycoplasma-like organism infections |
US20050085446A1 (en) * | 2003-04-14 | 2005-04-21 | Babu M.K. M. | Fluoroquinolone formulations and methods of making and using the same |
US8003616B2 (en) * | 2004-04-23 | 2011-08-23 | Albert Rory J | Composition for the treatment of ear infections and method |
US8153166B2 (en) * | 2006-06-08 | 2012-04-10 | Chih-Hsiung Lin | Composition for prophylaxis or treatment of urinary system infection and method thereof |
US20080114054A1 (en) * | 2006-11-14 | 2008-05-15 | Rath Microbes | Compositions and methods for reducing antimicrobial resistance of microbes |
-
2007
- 2007-05-28 MX MX2007006334A patent/MX2007006334A/es active IP Right Grant
-
2008
- 2008-05-27 CL CL2008001536A patent/CL2008001536A1/es unknown
- 2008-05-27 PE PE2008000899A patent/PE20090316A1/es not_active Application Discontinuation
- 2008-05-28 WO PCT/MX2008/000066 patent/WO2008147167A1/es active Application Filing
- 2008-05-28 AR ARP080102250A patent/AR067320A1/es unknown
- 2008-05-28 ES ES08766681T patent/ES2394736T3/es active Active
- 2008-05-28 BR BRPI0811627-0A2A patent/BRPI0811627A2/pt not_active Application Discontinuation
- 2008-05-28 EP EP08766681A patent/EP2149374B1/en not_active Not-in-force
- 2008-05-28 PL PL08766681T patent/PL2149374T3/pl unknown
-
2009
- 2009-11-12 GT GT200900295A patent/GT200900295A/es unknown
- 2009-11-13 EC EC2009009733A patent/ECSP099733A/es unknown
- 2009-11-13 CO CO09129713A patent/CO6241114A2/es not_active Application Discontinuation
-
2013
- 2013-01-10 CY CY20131100025T patent/CY1113544T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PE20090316A1 (es) | 2009-04-04 |
CO6241114A2 (es) | 2011-01-20 |
PL2149374T3 (pl) | 2013-05-31 |
BRPI0811627A2 (pt) | 2014-11-11 |
EP2149374B1 (en) | 2012-10-10 |
EP2149374A4 (en) | 2010-12-08 |
CL2008001536A1 (es) | 2009-04-03 |
AR067320A1 (es) | 2009-10-07 |
WO2008147167A1 (es) | 2008-12-04 |
ES2394736T3 (es) | 2013-02-05 |
ECSP099733A (es) | 2009-12-28 |
GT200900295A (es) | 2011-11-15 |
MX2007006334A (es) | 2009-02-18 |
EP2149374A1 (en) | 2010-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112015029512A2 (pt) | derivados de pirazolopirrolidina e seu uso no tratamento de doenças | |
CY1118017T1 (el) | Υποβαλλοντας σε αγωγη την ανεπαρκεια και το ελλειμμα βιταμινης d με 25-υδροξυβιταμινη d2 και 25-υδροξυβιταμινη d3 | |
CY1115289T1 (el) | Μεθοδοι αγωγης εναντι ασθενειας που σχετιζεται με φλεγμονη | |
BR112015029491A2 (pt) | derivados de imidazopirrolidinona e seu uso no tratamento de doença | |
EA201491358A1 (ru) | Вводимые перорально кортикостероидные композиции | |
CY1122626T1 (el) | Κορτικοστεροειδες που περιεχει τις συνθεσεις των δισκιων που διασπωνται απο το στομα για την ηωσινοφιλικη οισοφαγιτιδα | |
BR112012021086A2 (pt) | composições farmacêuticas de composto espiro-oxindole para administração tópica e seu uso como agentes terapêuticos | |
BR112019018615A2 (pt) | compostos antimicrobianos, composições e usos dos mesmos | |
BR112015029401A8 (pt) | derivados de pirazolo-pirrolidin-4-ona, seus usos, e composição e combinação farmacêuticas | |
BRPI0921705B8 (pt) | composição farmacêutica antimicrobiana e seu uso | |
WO2021168483A3 (en) | Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors | |
BR112013026257A2 (pt) | derivados de glicosídeo e usos dos mesmos para o tratamento de diabetes | |
MX2013003635A (es) | Compuestos de n-heteroarilo. | |
CL2022000875A1 (es) | Inhibidores del factor d del complemento para administración oral | |
CO2019004004A2 (es) | Composición farmacéutica y método para el tratamiento de la enfermedad del hígado graso no alcohólico | |
UY30847A1 (es) | Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales | |
BR112018072298A2 (pt) | tratamento de infecções pelo vírus da zika usando inibidores da alfa-glicosidase | |
EA201270747A1 (ru) | Композиции и способы для профилактики и лечения ран | |
BR112012020377A2 (pt) | utilização de um ou mais selecionado do grupo constituído por um composto da fórmula (i), uma mistura racêmica-diastereomérica e um isômero óptico do referido composto, e um sal farmaceuticamente aceitável e uma pródroga do mesmo, método, composição farmacêutica e kit para tratamento de caquexia e embalagem comercial | |
CY1113544T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει ενα συνδυασμο που σχηματιζεται απο τον αντιμικροβιακο παραγοντα σιπροφλοξασινη και τον αντιοξειδωτικο παραγοντα ασκορβικο οξυ για τη θεραπεια λοιμωξεων του ουροποιητικου συστηματος | |
EA201590847A1 (ru) | Новые ингибиторы rock | |
RU2013105513A (ru) | Производные 1-аминоалкилциклогексана для лечения воспалительных заболеваний кожи | |
CL2018003270A1 (es) | Una composición farmacéutica que comprende ácido carboxílico para tratar y prevenir congestión nasal. | |
PH12014501601A1 (en) | Artemisinin-based combination therapy for treating viral mediated disease | |
ECSP12012352A (es) | Agente terapéutico de liberación sostenida para la hipertensión y la disfunción renal |